Received Nov 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HIBV | HIB (PEDVAXHIB) | MERCK & CO. INC. | UNK | Y005366 | OT |
zero patients who received the affected administered doses reported any adverse issues or side effects; received PEDVAX HIB after temperature excursion:; This spontaneous report was received from other health professional concerning a patient of unspecified age and gender. The patient's medical history, past medications, concurrent conditions, concomitant medications and drug reactions/allergies were not reported. On 12-Sep-2025, doses of Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) Suspension for injection (PEDVAD HIB) underwent a temperature excursion at 8.9 degrees Celsius (C) for 15 minutes, 0 seconds. On 23-Sep-2025, the patient was vaccinated with an improperly stored dose of Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) Suspension for injection (PEDVAD HIB) batch/lot number Y005366, expiration date: 05-Nov-2026, administered as prophylaxis (exact dose, dosage regimen, anatomical location and route of administration were not reported) (product storage error.) It was reported that zero patients who received the affected administered doses reported any adverse issues or side effects (no adverse event.) This is one of several reports received from the same reporter.